Up-regulation of miR-335 predicts a favorable prognosis in esophageal squamous cell carcinoma

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 9, 2014, Pages 6213-6218

  Zhang, Bao Jun ^a   Gong, Hong Yan ^b   Zheng, Fang ^b   Liu, De Jun ^c   Liu, Hai Xia ^d  

^a Central Hospital of Xinxiang City   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XINXIANG MEDICAL UNIVERSITY   (China)

^c ZHENGZHOU UNIVERSITY   (China)

^d Henan Provincial Chest Hospital   (China)

Author keywords

Esophageal squamous cell carcinoma; miR 335; Prognosis; Quantitative real time PCR

Indexed keywords

MICRORNA; MIRN335 MICRORNA, HUMAN; TUMOR MARKER;

CANCER GRADING; CANCER STAGING; CASE CONTROL STUDY; ESOPHAGUS TUMOR; FEMALE; GENETICS; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SECONDARY; SQUAMOUS CELL CARCINOMA; TIME FACTOR; UPREGULATION;

BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; TIME FACTORS; UP-REGULATION;

EID: 84911862091     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wheeler JB, Reed CE. Epidemiology of esophageal cancer. Surg Clin North Am 2012; 92: 1077-1087.
2. Umar SB, Fleischer DE. Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Clin Pract Gastroenterol Hepatol 2008; 5: 517-526.
3. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
4. Yates LA, Norbury CJ, Gilbert RJ. The long and short of microRNA. Cell 2013; 153: 516-519.
5. Ni Y, Meng L, Wang L, Dong W, Shen H, Wang G, Liu Q, Du J. MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma. Gene 2013; 517: 197-204.
6. Zhang J, Cheng C, Yuan X, He JT, Pan QH, Sun FY. microRNA-155 acts as an oncogene by targeting the tumor protein 53-induced nuclear protein 1 in esophageal squamous cell carcinoma. Int J Clin Exp Pathol 2014; 7: 602-610.
7. Larne O, Martens-Uzunova E, Hagman Z, Edsjö A, Lippolis G, den Berg MS, Bjartell A, Jenster G, Ceder Y. miQ--a novel microRNA based diagnostic and prognostic tool for prostate cancer. Int J Cancer 2013; 132: 2867-2875.
8. Zu Y, Ban J, Xia Z, Wang J, Cai Y, Ping W, Sun W. Genetic variation in a miR-335 binding site in BIRC5 alters susceptibility to lung cancer in Chinese Han populations. Biochem Biophys Res Commun 2013; 430: 529-534.
9. Yan Z, Xiong Y, Xu W, Gao J, Cheng Y, Wang Z, Chen F, Zheng G. Identification of hsa-miR-335 as a prognostic signature in gastric cancer. PLoS One 2012; 7: e40037.
10. Xu Y, Zhao F, Wang Z, Song Y, Luo Y, Zhang X, Jiang L, Sun Z, Miao Z, Xu H. MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene 2012; 31: 1398-1407.
11. Lynch J, Fay J, Meehan M, Bryan K, Watters KM, Murphy DM, Stallings RL. MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-ß signalling pathway. Carcinogenesis 2012; 33: 976-985.
12. Cao J, Cai J, Huang D, Han Q, Chen Y, Yang Q, Yang C, Kuang Y, Li D, Wang Z. miR-335 Represents an Independent Prognostic Marker in Epithelial Ovarian Cancer. Am J Clin Pathol 2014; 141: 437-42.
13. Zhang T, Wang Q, Zhao D, Cui Y, Cao B, Guo L, Lu SH. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. Clin Sci 2011; 121: 437-447.
14. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12: 861-874.
15. Jansson MD and Lund AH. MicroRNA and cancer. Mol Oncol 2012; 6: 590-610.
16. Kasinski AL and Slack FJ. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011; 11: 849-864.
17. Dohi O, Yasui K, Gen Y, Takada H, Endo M, Tsuji K, Konishi C, Yamada N, Mitsuyoshi H, Yagi N, Naito Y, Tanaka S, Arii S, Yoshikawa T. Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma. Int J Oncol 2013; 42: 411-418.
18. Wang Y, Zhao W, Fu Q. miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells. Mol Cell Biochem 2013; 384: 105-111.
19. Jiang J, Sun X, Wang W, Jin X, Bo X, Li Z, Bian A, Jiu J, Wang X, Liu D, Hui X, Wang Y, Wang A, Ding L. Tumor microRNA-335 expression is associated with poor prognosis in human glioma. Med Oncol 2012; 29: 3472-3477.
20. Shi L, Jiang D, Sun G, Wan Y, Zhang S, Zeng Y, Pan T, Wang Z. miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas. J Neurooncol 2012; 110: 155-162.
21. Tomé M, López-Romero P, Albo C, Sepúlveda JC, Fernández-Gutiérrez B, Dopazo A, Bernad A, González MA. miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ 2011; 18: 985-995.